The Reuters Pharma 2023 event is live in Barcelona and pharmaphorum is on site to provide readers with rolling coverage of the speakers and concepts as unfolds over the next few days.
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho